Denosumab for Elderly Men with Osteoporosis: A Cost-Effectiveness Analysis from the US Payer Perspective Tekijä Stuart Silverman, Irene Agodoa, Morgan Kruse, Anju Parthan, Eric Orwoll

Hae kokoteksti